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Abstract:	 The aberrant misfolding and subsequent conversion of 
monomeric protein into amyloid aggregates characterizes many 
neurodegenerative disorders, including Parkinson’s and Alzheimer’s 
diseases. These aggregates are highly heterogeneous in structure, 
generally of low abundance, and typically smaller than the diffraction 
limit of light (~250 nm). To overcome these challenges, we have 
developed a method to characterize protein aggregates at the 
nanometer scale without the need for a conjugated fluorophore. Using 
a combination of DNA PAINT and an amyloid specific aptamer, we 
demonstrate that this technique is able to detect and super-resolve a 
range of aggregated species, including those formed by α-synuclein 
and amyloid-β. Additionally, this method enables endogenous protein 
aggregates within cells to be characterized. We found that neuronal 
cells derived from patients with Parkinson’s disease contain a larger 
number of protein aggregates than those from healthy controls. 
Protein misfolding and aggregation is closely associated with the 
development of many neurodegenerative disorders, such as 
Alzheimer’s disease (AD) and Parkinson’s disease (PD)[1]. In AD, 
the protein tau is deposited in intracellular inclusions[2], while the 
amyloid beta (Aβ) peptide is in extracellular plaques. Similarly, in 
PD, aggregates of the protein α-synuclein (αS) are found in Lewy 
bodies[3] within neuronal cells. There proteins are often heavily 
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Figure 1. The concept of ADPAINT. (a) Schematic representation of 
ADPAINT shows an aggregate bound by multiple aptamers. The DNA 
docking strand (red) on the aptamer is transiently bound by the 
complementary imaging strand (green) to generate a SR image. (b) 
Example time montage of an oligomer undergoing ADPAINT. Each sub-
image is separated by 0.5 s, moving through time from left to right then 
top to bottom, and the scale bar is 1 µm. (c) Intensity profile of the 
oligomer in (b). Each intensity burst represents the binding of the imaging 
strand to the aptamer. Gray- raw intensity profile, Blue- using a Chung-
Kennedy filter[31] with a window of 5 frames applied. (d) Examples of 
diffraction limited (DL, using Thioflavin-T) and super-resolved (SR, using 
ADPAINT) images of an αS and Aβ oligomer and fibril. The scale bar is 
500 nm. 
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post-translationally modified, for example αS undergoes 
phosphorylation, nitration and truncation[4–6], making it important 
to be able to characterize the real endogenous aggregates formed 
in cells, since these may  differ from those formed by unmodified 
proteins.    
More recently, soluble nanometer-sized protein oligomers 
have been identified as the major cytotoxic species in AD and 
PD[7–10], but the study of such species has remained challenging, 
as they tend to be low in abundance and to adopt a wide range of 
heterogeneous structures. To overcome this problem we have 
developed an array of single-molecule techniques[11–14] to observe 
oligomeric species individually, and have applied them to 
characterize the aggregation pathway of several disease-related 
proteins in vitro. In many such methodologies, the protein of 
interest needs to be tagged with either an organic fluorophore or 
a fluorescent protein. This is very challenging for in vivo or in cell 
imaging, and in some cases the label may have an adverse effect 
on the behavior of the protein[15]. Alternatively, dyes such as 
thioflavin-T/S (ThT/S) or the pentameric form of formyl thiophene 
acetic acid (pFTAA), whose fluorescence in each case is 
enhanced upon binding to amyloid structures, can be used to 
detect protein aggregates. We have recently used such dyes in 
combination with total internal reflection fluorescence microscopy 
(TIRF) microscopy to image individual aggregates in human 
cerebrospinal fluid (CSF) in a diffraction-limited manner[16]. Such 
dyes, however, bind to other cellular components limiting their 
versatility[17], and may not be sensitive to the smaller oligomers, 
which in addition to being major therapeutic targets, could also be 
biomarkers for neurodegeneration[16,18]. Furthermore, 
conventional far-field microscopy techniques face a limit in their 
resolving capability imposed by the optical diffraction barrier. As 
many sub-cellular structures are known to be affected by toxic 
protein aggregates[19,20], it is important to define the morphology 
and location of aggregates in the cellular milieu in order to 
understand the interplay between protein aggregation and the 
loss of cellular homeostasis.      
 We have employed the use of an aptamer previously 
reported to recognize oligomers and fibrils formed from αS and 
Aβ[21] to enable the sensitive and specific visualization of protein 
aggregates at the nanoscale. Aptamers are single-stranded 
oligonucleotides developed to have high affinity and specificity, 
and can be made for almost any molecule or structure[22,23]. The 
advent of super-resolution (SR) microscopy methods[24] has 
improved the resolution of optical methods. Recently, an SR 
method, referred to as DNA PAINT (point accumulation in 
nanoscale topography), has been developed[25,26]. The technique 
utilizes short complementary strands of DNA; a “docking” strand 
is conjugated to an antibody or protein of interest whilst its 
complementary “imaging” strand is labelled with an organic 
fluorophore. We have extended the aptamer sequence with a 
docking strand sequence (Figure 1a, SI Table 1), to generate SR 
images of protein aggregates (Figure 1d), and we herein refer to 
this method as Aptamer DNA PAINT (ADPAINT). The repeated 
transient binding of the imaging strand to the docking strand 
(Figure 1a,b,c) allows it to be spatially localized, enabling the 
reconstruction of a SR image. Additional burst montages are 
shown in SI Figure 2, providing a more complete view of the 
variation in fluorescent bursts caused by the stochastic binding of 
imaging strand to the docking strand. DNA PAINT can be realised 
using both TIRF microscopy, and more recently, spinning disk 
confocal microscopy[27]. Examples of oligomers and fibrils of both 
αS and Aβ imaged using ADPAINT are shown in Figure 1d (full 
fields of view shown in SI Figures 3 and 4). A control experiment 
using just the imaging strand (without aptamer) showed little non-
specific binding of the imaging strand to the aggregates (SI Figure 
5). The aptamer is specific to the conformation of the aggregates, 
and so these can be detected even amongst an excess of 
monomer. Furthermore, for primary and secondary antibodies, 
the size of the probe can add a linkage error of 15 nm[28], whereas 
the small size of aptamers enables them to bind at a high density,  
Figure 2. ADPAINT enables the imaging of a range of species formed 
during the aggregation of αS. (a) Examples aggregates are shown in SR 
on the left, with their corresponding nearest neighbor plots shown on the 
right, highlighting hotspots of localization density. The scale bar is 200 
nm. (b) The number of aggregates increases over the time-course, and 
(c) the number of localizations also increases as the species get larger, 
which is shown by (d) as the mean length increases. Data shown are 
mean ± SD of three independent aggregation reactions. (e) The 
percentage of liposomes permeabilized upon addition of aggregates from 
the different time-points (mean ± SD over 16 FOV (69 x 69 µm)). 
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and at a close proximity to their epitopes, leading to a high 
imaging resolution, as has also been shown with DNA PAINT and 
affirmers[29]. Typically, we achieve a localization precision of ~10 
nm and a resolution of ~25 nm (SI Table 2), with a limit of 
detection of ~30 pM of aggregates (Supporting Information). This 
enables us to quantify the oligomers formed during physiologically 
relevant aggregation reactions. Each image was acquired over 
200 s; however, since PAINT-based techniques are not limited by 
photobleaching[30], this time can be lengthened to localize a 
greater number of binding events in order to obtain a higher 
resolution image of the protein or cellular structure of interest.  
To assess the ability of ADPAINT to study the heterogeneity 
of complex aggregation mixtures, a solution of monomeric αS was 
incubated under conditions previously described to result in its 
aggregation[7,11]. At early time-points in the reaction, only a few 
aggregates were detected, and these were predominantly small 
(< 400 nm in length for the first 6 h) and rounded, consistent with 
the expected appearance of oligomers (Figure 2a). After 10 h, 
fibrils were detected. To visualize the distribution of binding sites 
within each aggregate, we color-coded the localizations according 
to their local (typically within 40-50 nm) molecular density. The 
resulting images show maps of the local molecular density of 
individual aptamer binding sites, revealing a highly non-uniform 
distribution, particularly in the later aggregates (right panel in each 
case). This shows that the aggregate structure is not 
homogeneous, but instead varies at the nanoscale, a finding that 
is made possible through this method. Further analysis of the 
ADPAINT images showed that the number of aggregates 
increased over time, consistent with the high aggregation 
propensity of αS (Figure 2b).  Unlike with antibodies in which 
labelling stoichiometrically can be challenging, each aptamer is 
labelled with a single DNA docking strand allowing for quantitative 
imaging. We have taken advantage of this by quantifying the 
number of localizations per aggregate, finding that this increased 
over time (Figure 2c, SI Figure 6). Additionally, the aggregates 
also got larger, as indicated by the increase in their mean length 
(Figure 2d, SI Figure 7). 
The permeabilization of membranes has been suggested to 
be the most ubiquitous toxic mechanism associated with protein 
aggregates[31–35]. We have recently developed a method to 
characterize the ability of protein aggregates to permeabilize lipid 
membranes[8] (details are given in Supporting Information), and 
have used this within this study, finding that the earlier aggregates 
caused a higher level of influx compared to those present at later 
stages of the aggregation process (those around 600 nm in 
length) (Figure 2e). Additionally, the binding of the aptamer to the 
aggregates did not inhibit their ability to permeabilize the lipid 
membranes, and the aptamer itself displayed no propensity to 
alter these membranes (SI Figure 8). Thus, it appears likely that 
ADPAINT can be applied to characterize the structures of the 
pathological aggregates without altering the functional states of 
the protein or the cell membrane.  
We next used ADPAINT to investigate aggregate formation 
in a cellular model of PD. Missense mutations[13,36–40], and 
duplications or triplications of the SNCA gene, which encodes αS, 
lead to autosomal dominant early-onset PD[41,42]. It has previously 
been shown that the formation of αS oligomers in vitro is 
concentration dependent[12], and ADPAINT now enables us to 
determine whether this dependence is reflected within cellular 
models that overexpress αS. We made use of induced pluripotent 
stem cells (iPSCs) from a PD patient with a triplication of the 
SNCA gene, and from a healthy control unaffected by the disease 
to generate cortical neurons. Although SR methods have been 
utilized to image fibrils in cells, these are typically exogenously 
Figure 3. ADPAINT in iPSCs. (a) iPSCs from a PD patient with a triplication 
of the SNCA gene, and a healthy control. Protein aggregates were imaged 
using pFTAA (green) or ADPAINT (red). The scale bars are 5 µm and 500 
nm in the zoom. Compared to control cells, SNCA triplication cells show (b) 
significantly more aggregates and an increase in the (c) number of 
localizations, and (d) the average length of the aggregates. The data shown 
are means ± SD of at least 27 fields of view. * p < 0.05, ** p < 0.001, *** p 
< 0.0001; analyzed by t-test.  
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added aggregates generated from fluorophore labelled 
protein[43,44,28,45–47], this is the first case in which a specific probe 
for aggregates is used, and so enables the SR imaging of 
unlabeled, endogenous aberrant protein complexes. These were 
imaged in fixed, permeabilized cells using both ADPAINT at the 
SR-level, and in a diffraction-limited manner using pFTAA, a dye 
which recognizes β-sheet structures and becomes fluorescent 
upon binding to protein aggregates[48,49]. To image at a greater 
depth into the cells, the illumination was changed to oblique-angle 
epifluorescence. Figure 3 shows examples of human iPSC-
derived neurons with and without the SNCA triplication after being 
plated and stained with pFTAA (green) (further examples are 
shown in SI Figure 9). PFTAA not only binds to the aggregates, 
which appear as brighter spots, but also interacts with cellular 
organelles and membranes, preventing the aggregates from 
being identified or their precise location within the cell being 
determined. Unlike pFTAA, the aptamer has a high specificity, 
and only small clusters of binding events are detected within the 
cytosol. Due to the background fluorescence being higher in 
oblique-angle epifluorescence than in TIRF, the resolution we 
achieved within cells was lower than he resolution achieved for 
the in vitro formed aggregates (SI Table 2). Quantification of these 
images shows that there are significantly (p < 0.0001) more 
aggregates in the cells derived from the individual carrying a 
triplication of the SNCA locus compared to iPSC-derived neurons 
from the healthy control. We found that the species detected in 
these experiments resemble those formed early on in the in vitro 
aggregation pathway (0-2 hours) shown in Figure 2, having ~45 
localizations per aggregate (Figure 3c), and being <150 nm in 
length (Figure 3d). Furthermore, the aggregates detected in the 
cells having the SNCA triplication locus give rise to significantly 
more localizations (Figure 3c) and are larger (Figure 3d) than 
those in the healthy control cells. Given the likelihood of toxicity 
arising directly from these aggregates, this observation could help 
explain the neuronal cell death associated with PD.  
One of the significant advantages of ADPAINT is the ability 
of the aptamer to selectively bind to protein aggregates and not 
the excess of monomeric protein which is present in cells. As a 
comparison, we used the commercially available MJF14-6-4-2 
filament antibody, which detects an epitope that is only present in 
aggregates and not in the monomeric protein[50], and the Alexa 
Fluor 405 labeled aptamer to detect dual labeled aggregates of 
αS added to iPSC-derived neurons (SI Figure 10). In the case of 
the MJF14-6-4-2 antibody, there was non-specific staining of 
regions of the cell that did not contain aggregated αS, whereas 
the aptamer only detected dual-labeled aggregates. Furthermore, 
the larger size of antibodies can add a further 10-15 nm between 
the target and the labeled probe[28]. When used with DNA PAINT, 
the same MJF14-6-4-2 antibody (SI Figure 11), was unable to 
resolve individual aggregates, but instead there was diffuse 
staining in both the SNCA triplication and control cells.  
In conclusion, we have developed an SR method to 
characterize the toxic species formed during neurodegenerative 
diseases. We have used ADPAINT to characterize both in vitro 
aggregates αS and Aβ, and also endogenous unlabeled 
oligomers formed in patient-derived neurons. Interestingly, we 
found that the aggregates formed early in the in vitro aggregation 
closely resemble the morphology of those found within human 
iPSC-derived cortical neurons, and that these appear to be most 
responsible for disrupting lipid membranes, Although only imaged 
at one stage in the lifetime of the iPSC-derived cortical neurons, 
this method can also be used to determine how such species 
develop as cells age, potentially yielding further insights into the 
progression of neurodegenerative diseases.    
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